Scios
ORG
Scios
The troubled Scios unit of Johnson & Johnson told employees yesterday that it would lay off 150 of its approximately 900 workers. Scios has struggled since sales of its flagship drug, the heart failure treatment Natrecor, began declining last year over safety concerns. Scios is also the subject of a Justice Department investigation into whether it improperly promoted Natrecor for an unapproved use, according to company disclosures to the Securities and Exchange Commission.